Rankings
▼
Calendar
BBLG Q3 2025 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
Q3 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$715,274
Net Income
-$666,737
EPS (Diluted)
$-0.37
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$591,384
Free Cash Flow
-$591,384
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$6M
Total Liabilities
$334,282
Stockholders' Equity
$6M
Cash & Equivalents
$6M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$715,274
-$951,021
+24.8%
Net Income
-$666,737
-$941,002
+29.1%
← FY 2025
All Quarters
Q4 2025 →